Phase 2
N=30
Topical Treatment of Under Eye Dark Circles and Swelling
Edema
Bottom Line
View on ClinicalTrials.gov: NCT01172522 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention — 0; 0 participants — p==1
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Fexofenadine (Drug); Placebo (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- The Connecticut Sinus Center, PC
- Primary completion
- Dec 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention |
0; 0 | =1 |
Summary
This study examines topical treatment of under eye circles and swelling.
Eligibility Criteria
Inclusion Criteria
- Under eye dark circles and swelling
Exclusion Criteria
- Under age 18
- Allergy to tested medicines
Data sourced from ClinicalTrials.gov (NCT01172522). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.